Researchers are calling for better implementation of ICD therapy after an analysis of the Swedish HF Registry found the devices to be beneficial—but underused—among patients with HFrEF.

Victims of cardiac arrest are more likely to recover with good brain function if they’re subject to “cooling” after resuscitation, UPI.com reported via HealthDay News Oct. 2.

An analysis of the long-running Framingham Heart Study has revealed that exposure to secondhand smoke in childhood increases a person’s lifetime risk of atrial fibrillation.

A singular, high-dose beam of radiation could improve survival odds in patients with ventricular tachycardia, many of whom are too sick to undergo conventional therapy, researchers reported at the ASTRO meeting in Chicago Sept. 15.

The incidence of CIED infection in the U.S. has been increasing for the past two decades, according to work published in JACC: Clinical Electrophysiology this month.

Artificial intelligence is emerging as a hot tool for diagnosing rhythm disorders.

More than 30% of Danish heart patients with an ICD resume driving during a “banned period” following their index procedure, researchers reported at the ESC Congress in Paris on Sept. 3.

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.